Search

everythinglearnresearchcommunity

for

Search:↓

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Baricitinib works better than methotrexate for severe alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

JAK inhibitors are effective for long-term management of alopecia areata.